{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Akiyama H"],"funding":["U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)","Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)","U.S. Department of Health & Human Services | NIH | National Cancer Institute","Daiichi Sankyo Company","Uehara Memorial Foundation","NCI NIH HHS","Cancer Prevention and Research Institute of Texas"],"journal":["Blood cancer journal"],"pagination":["76"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12022017"],"repository":["biostudies-literature"],"pubmed_title":["Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia."],"pmcid":["PMC12022017"],"funding_grant_id":["P30 CA016672","NA","1 R50 CA243707-01A1","RP121010"],"pubmed_authors":["Bedoy AD","Basyal M","Muftuoglu M","Andreeff M","Wang J","Ma W","Zhang W","Rampal RK","Chang KH","Akiyama H","Honma D","Oluwole OO","Huang X","Daver NG","Tsutsumi S","Bixby DL","Hirschi Z","Nishida Y"],"additional_accession":[]},"is_claimable":false,"name":"Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Apr","modification":"2025-07-10T03:08:55.703Z","creation":"2025-07-10T03:08:55.703Z"},"accession":"S-EPMC12022017","cross_references":{"pubmed":["40274779"],"doi":["10.1038/s41408-025-01266-0"]}}